Arnicolide D: a multi-targeted anticancer sesquiterpene lactone—preclinical efficacy and mechanistic insights-Reference-Cited by-同舟云学术

Arnicolide D: a multi-targeted anticancer sesquiterpene lactone—preclinical efficacy and mechanistic insights

Published:2024-04-23 Issue: Volume: Page:
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmiedeberg's Arch Pharmacol

Author:

Mangalpady Shivaprasad Shetty,Peña-Corona Sheila I.,Borbolla-Jiménez Fabiola,Kaverikana Rajesh,Shetty Shobhitha,Shet Vinayaka Babu,Almarhoon Zainab M.,Calina Daniela,Leyva-Gómez Gerardo,Sharifi-Rad Javad

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00210-024-03095-7.pdf

Reference96 articles.

1. Abu-Izneid T, Rauf A, Shariati MA et al (2020) Sesquiterpenes and their derivatives-natural anticancer compounds: an update. Pharmacol Res 161:105165. https://doi.org/10.1016/j.phrs.2020.105165

2. Afify SM, Oo AKK, Hassan G et al (2021) How can we turn the PI3K/AKT/mTOR pathway down? Insights into inhibition and treatment of cancer. Expert Rev Anticancer Ther 21:605–619. https://doi.org/10.1080/14737140.2021.1918001

3. Avram S, Coricovac D-E, Pavel IZ et al (2017) Standardization of A375 human melanoma models on chicken embryo chorioallantoic membrane and Balb/c nude mice. Oncol Rep 38:89–99. https://doi.org/10.3892/or.2017.5658

4. Basu N, Narad P, Guptasarma ML et al (2022) Computational and in vitro approaches to elucidate the anti-cancer effects of Arnica montana in hormone-dependent breast cancer. Homeopathy 111:288–300. https://doi.org/10.1055/s-0042-1743565

5. Beekman AC, Woerdenbag HJ, van Uden W et al (1997) Structure−cytotoxicity relationships of some helenanolide-type sesquiterpene lactones. J Nat Prod 60:252–257. https://doi.org/10.1021/np960517h